Positives

• Patients with GERD on pantoprazole commonly report symptom relief and quality-of-life improvement after 8 weeks of treatment, a relevant duration for Long COVID GERD flares PMC.
• Mast cell experts list pantoprazole among PPIs added to MCAS protocols when reflux breaks through H1 and H2 blockade The Mast Cell Disease Society.
• Patients on PPIs through Long COVID describe relief from burning chest pain, regurgitation, and post-meal nausea Mayo Clinic.

Negatives

• Forum members flagged that GI problems are a common comorbidity in ME/CFS, and a PPI such as pantoprazole can resolve the acid symptoms while underlying motility or microbiome issues remain — the drug is often symptomatic rather than curative Phoenix Rising.
• Long-term PPI use can deplete vitamin B1 (thiamine) and other micronutrients, a particular concern in a patient population already prone to thiamine deficiency — some forum members who tried pantoprazole for H. pylori eradication reported fatigue and cognitive side effects that resolved after discontinuation Phoenix Rising.

Hurdles & Side Effects

• Pantoprazole appears as a component of the Pretorius/Laubscher triple-anticoagulant protocol for Long COVID microclots (gastric protection alongside aspirin + clopidogrel + DOAC), so patients on that protocol often encounter pantoprazole as part of a larger regimen rather than a standalone treatment Phoenix Rising.
• Within the PPI class, pantoprazole is often preferred for patients on triple-therapy protocols because it has fewer CYP2C19-mediated drug interactions than omeprazole or esomeprazole — forum members note that direct patient reports naming pantoprazole specifically are less common than reports naming omeprazole Phoenix Rising.